GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pak Fah Yeow International Ltd (HKSE:00239) » Definitions » EBIT

Pak Fah Yeow International (HKSE:00239) EBIT : HK$122.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Pak Fah Yeow International EBIT?

Pak Fah Yeow International's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was HK$60.9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$122.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Pak Fah Yeow International's annualized ROC % for the quarter that ended in Jun. 2024 was 20.31%. Pak Fah Yeow International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 39.15%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Pak Fah Yeow International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 36.85%.


Pak Fah Yeow International EBIT Historical Data

The historical data trend for Pak Fah Yeow International's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pak Fah Yeow International EBIT Chart

Pak Fah Yeow International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.02 -33.25 47.49 38.41 129.42

Pak Fah Yeow International Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.19 37.23 68.30 61.12 60.88

Competitive Comparison of Pak Fah Yeow International's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Pak Fah Yeow International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pak Fah Yeow International's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pak Fah Yeow International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Pak Fah Yeow International's EV-to-EBIT falls into.


;
;

Pak Fah Yeow International EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$122.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pak Fah Yeow International  (HKSE:00239) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Pak Fah Yeow International's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=152.796 * ( 1 - 21.57% )/( (615.713 + 564.171)/ 2 )
=119.8379028/589.942
=20.31 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=907.465 - 18.663 - ( 277.607 - max(0, 44.185 - 317.274+277.607))
=615.713

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Pak Fah Yeow International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=121.766/( ( (326.596 + max(-9.816, 0)) + (295.439 + max(-68.059, 0)) )/ 2 )
=121.766/( ( 326.596 + 295.439 )/ 2 )
=121.766/311.0175
=39.15 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(17.435 + 12.197 + 0) - (18.663 + 0 + 20.785)
=-9.816

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.403 + 11.42 + 0) - (69.286 + 0 + 16.596)
=-68.059

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Pak Fah Yeow International's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=122.007/331.122
=36.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pak Fah Yeow International EBIT Related Terms

Thank you for viewing the detailed overview of Pak Fah Yeow International's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Pak Fah Yeow International Business Description

Traded in Other Exchanges
N/A
Address
200 Gloucester Road, 11th Floor, Wanchai, Hong Kong, HKG
Pak Fah Yeow International Ltd, with its subsidiaries, is engaged in the manufacture and distribution of healthcare products, including Hoe Hin branded products. It also engages in real estate investment and treasury investment businesses. It has three business segments, namely healthcare, property investments, and treasury investments. The Company derives the majority of its revenues from the Healthcare segment.
Executives
Gan Fock Wai Stephen 2101 Beneficial owner
Brooke Jonathan William 2101 Beneficial owner

Pak Fah Yeow International Headlines

No Headlines